Preview

Медицинский Совет

Расширенный поиск

Аллергический ринит: современная оценка медико-социальных аспектов и способов лечения интраназальные кортикостероиды в лечении ринитов

https://doi.org/10.21518/2079-701X-2018-17-187-191

Полный текст:

Аннотация

В статье представлены вопросы эпидемиологии, патогенеза и лечения аллергического ринита. Рассмотрены различные виды неаллергического ринита, взаимосвязь аллергического ринита и полипозного риносинусита, эозинофильного неаллергического ринита, медикаментозного ринита. Подробно рассмотрена ведущая роль топических глюкокортикостероидов в терапии ринита, в том числе неаллергического.

Об авторе

С. В. Царев
ФГБУ «Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства России
Россия

Царев Сергей Владимирович – доктор медицинских наук, врач поликлинического отделения №1

Москва 



Список литературы

1. http: //www.worldallergy.org/wao-white-bookonallergy

2. Pols DHJ, Wartna JB, Moed H, van Alphen EI, Bohnen AM, Bindels PJ. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review. Scand J Prim Health Care, 2016, 34: 143-150.

3. Hill DA, Grundmeier RW, Ram G, Spergel JM. The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: retrospective cohort study. BMC Pediatr, 2016, 16: 133.

4. Kim JL, Brisman JAl, Aberg MA, Forslund HB, Winkvist A, Toren K. Trends in the prevalence of asthma, rhinitis and eczema in 15 year old adolescents over an 8 year period. Respir Med, 2014, 108: 701-708.

5. Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM еt al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol, 2013, 131: 805-812.

6. Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol, 2012, 130: 894-901.

7. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A еt al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organiza tion, GA(2)LEN and AllerGen). Allergy, 2008, 63: 8-160.

8. Богова А.В., Ильина Н.И., Лусс Л.В. Тенденции в изучении эпидемиологии аллергических заболеваний в России за последние 10 лет. Российский аллергологический журнал, 2008, 6: 3-14.

9. Lindner M. When allergies attack. Fortune, 2010, 162(2): 14.

10. Cardell L-O, Olsson P, Andersson M, Welin KO, Svensson J, Tennvall GR et al. TOTALL: high cost of allergic rhinitis – a national Swedish population-based questionnaire study. NPJ Prim Care Respir Med, 2016, 26: 15082.

11. Linneberg A, Dam Petersen K, Hahn-Pedersen J, Hammerby E, Serup-Hansen N, Boxall N. Burden of allergic respiratory disease: a systematic review. Clin Mol Allergy, 2016, 14: 12.

12. Canonica GW, Mullol J, Pradalier A, Didier A. Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in Europe and the United States. World Allergy Organ J, 2008, 1: 138-144.

13. Meltzer EO, Gross GN, Katial R, Storms, WW. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract, 2012, 61: 5-10.

14. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol, 2017, 140: 950-958.

15. Poddighe D, Gelardi M, Licari A, del Giudice M M, Marseglia GL. Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management. World J Methodol, 2016, 6: 200–213.

16. Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M et al. Impact of Rhinitis on Work Productivity: A Systematic Review. J Allergy Clin Immunol Pract, 2017, 6: 1274-1286.

17. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med, 2000, 162: 1391-1396.

18. Schatz M, Zeiger RS. Telephone-based environmental control interventions in asthmatic patients: what are patients willing to do? Ann Allergy Asthma Immunol, 2012, 109: 99-102.

19. Braido F, Arcadipane F, Marugo F, Hayashi M, Pawankar R. Allergic rhinitis: current options and future perspectives. Curr Opin Allergy Clin Immunol, 2014, 2: 168-176.

20. Suzaki H. Action mechanisms of glucocorticoids on rhinosinusitis. Asian Rhinology Journal, 2013, 1: 3-13.

21. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol, 1998, 101: 434-439.

22. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung, 1998, 48: 956-960.

23. Demoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol, 2008, 29: 403-413.

24. Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol, 2009, 158(3): 260-271.

25. Kaliner MA. Nonallergic rhinopathy (formerly known as vasomotor rhinitis). Immunol Allergy Clin North Am, 2011, 31: 441-455.

26. Kern R. Allergy: a constant factor in the etiology of so-called mucous nasal polyps. J Allergy, 1993, 4: 483.

27. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol. Suppl, 2012, 50: 1-298.

28. Suzaki H. Action mechanisms of glucocorticoids on rhinosinusitis. Asian Rhinology Journal, 2013, 1: 3-13.

29. Potter PC, Pawankar R. Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis. World Allergy Organ J, 2012, 5: 14-17.

30. Ahmadiafshar A, Farjd HR, Moezzi F, Mousavinasab N. Nasal polyposis in patients with asthma and allergic rhinitis. J Laryngol Otol, 2012, 126: 780-783.

31. Польнер С.А., Козаренко Е.А., Шевцов Е.А. Целесообразность и место риносептопластики в комплексном лечении аллергического ринита и бронхиальной астмы. Цитокины и воспаление, 2012, 12(3): 130-132.

32. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy, 2007, 62: 17–25.

33. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy, 2017, 72: 1657-1665.

34. Saco TV, Pepper A, Casale TB. Uses of biologics in allergic diseases: What to choose and when. Ann Allergy Asthma Immunol, 2018, 120: 357-366.


Просмотров: 92


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)